Wellington Partners
Investor profile
Investment firmVenture capital
Wellington Partners has backed 70 European tech companies across 116 funding rounds between 2002 and 2026, joining rounds totalling €5.9B. Most active in Healthtech and Software. Data as of Nov 2026.
Also recorded as: Wellington Management
Deals
116
distinct rounds
Companies
70
backed
Active span
2002–2026
25 yrs
Total round €
€5.9B
sum of rounds joined
Deals by year
distinct rounds / yearWellington Partners — deals by year — interactive chart.
Data table
| Wellington Partners — deals by year | |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 6 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 8 |
| 2010 | 1 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 8 |
| 2014 | 13 |
| 2015 | 7 |
| 2016 | 14 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 4 |
Top sectors
by dealsWellington Partners — top sectors — interactive chart.
Data table
| Wellington Partners — top sectors | |
|---|---|
| Healthtech | 36 |
| Software | 17 |
| Media | 14 |
| E-commerce | 13 |
| Consumer | 9 |
| Energy | 7 |
| Telecom | 7 |
| Cleantech | 6 |
| Fintech | 6 |
| Travel | 5 |
Stages
by dealsWellington Partners — stages — interactive chart.
Data table
| Wellington Partners — stages | |
|---|---|
| Series A | 35 |
| Series B | 29 |
| Series C | 13 |
| Seed | 11 |
| Other | 9 |
| Series D+ | 7 |
| Growth/Late | 6 |
| Early VC | 4 |
| Debt | 2 |
Countries
by dealsWellington Partners — countries — interactive chart.
Data table
| Wellington Partners — countries | |
|---|---|
| UK | 40 |
| Germany | 38 |
| Switzerland | 9 |
| France | 6 |
| Sweden | 6 |
| Denmark | 5 |
| Austria | 2 |
| Belgium | 2 |
| Finland | 2 |
| Iceland | 2 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Balderton Capital8
- High-Tech Gründerfonds (HTGF)8
- btov Partners6
- Earlybird Venture Capital6
- NRW.BANK5
- Atomico4
- BayTech Venture Capital4
- Boehringer Ingelheim Venture Fund4
- Intel Capital4
- OpenOcean4
- Playfair Capital4
- Advent Venture Partners3
- BaltCap3
- Bayern Kapital3
- Benchmark3
- Cipio Partners3
- Eight Roads Ventures3
- Forbion3
- Insight Partners3
- Novo Holdings3
- Octopus Ventures3
- Passion Capital3
- AAC Capital Partners2
- Accel2
- Adjuvant Capital2
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Nscale | UK | 1 | €3.0B |
| Tubulis Technologies | Germany | 1 | €308M |
| Oxford Nanopore Technologies | UK | 1 | €225M |
| Dataiku | France | 1 | €190M |
| Freeline Therapeutics | UK | 2 | €178M |
| PowaTAG | UK | 2 | €121M |
| Powa Technologies | UK | 2 | €121M |
| NUCLIDIUM | Switzerland | 2 | €113M |
| IOmx Therapeutics | Germany | 2 | €105M |
| Adaptimmune | UK | 1 | €79M |
| Heliatek | Germany | 3 | €78M |
| MinervaX | Denmark | 2 | €76M |
| Buyapowa | UK | 1 | €72M |
| Sidekick Health | Iceland | 2 | €69M |
| Uromems | France | 2 | €56M |
| Encord | UK | 1 | €50M |
| Payoneer | Israel | 1 | €46M |
| Aignostics | Germany | 2 | €46M |
| Quanta Fluid Solutions | UK | 2 | €44M |
| Quanta | UK | 1 | €42M |
| Truphone | UK | 2 | €39M |
| Nightstar | UK | 1 | €39M |
| Hailo | UK | 3 | €38M |
| Hilo (Aktiia) | Switzerland | 1 | €37M |
| Bookatable (Livebookings) | UK | 3 | €36M |
| BridgeCo | Switzerland | 3 | €35M |
| Spotify | Sweden | 1 | €35M |
| Snipr Biome | Denmark | 1 | €35M |
| Enecsys | UK | 2 | €35M |
| CRISPR Therapeutics | Switzerland | 1 | €35M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Oxford Nanopore Technologies | Other | €225M | 2021-05 |
| Dataiku | Series D+ | €190M | 2022-12 |
| Freeline Therapeutics | Series C | €107M | 2020-07 |
| NUCLIDIUM | Series B | €84M | 2025-07 |
| Adaptimmune | Series A | €79M | 2014-09 |
| Buyapowa | Other | €72M | 2014-11 |
| Freeline Therapeutics | Series C | €71M | 2020-07 |
| IOmx Therapeutics | Series B | €65M | 2021-10 |
| PowaTAG | Series B | €64M | 2014-11 |